Wang, C N <br/><br/>
Nepalolide A inhibits the expression of inducible nitric oxide synthase by modulating the degradation of IkappaB-alpha and IkappaB-beta in C6 glioma cells and rat primary astrocytes.  [electronic resource] 

 -  British journal of pharmacology  Sep 1999 
 - 345-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1188 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjp.0702785  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthracenes--pharmacology<br/>Astrocytes--drug effects<br/>Biotransformation--drug effects<br/>Blotting, Western<br/>Brain Neoplasms--metabolism<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>DNA-Binding Proteins--metabolism<br/>Depression, Chemical<br/>Electrophoresis<br/>Enzyme Inhibitors--pharmacology<br/>Glioma--metabolism<br/>I-kappa B Proteins<br/>Interferon-gamma--antagonists & inhibitors<br/>NF-KappaB Inhibitor alpha<br/>NF-kappa B--antagonists & inhibitors<br/>Nitric Oxide Synthase--antagonists & inhibitors<br/>Nitric Oxide Synthase Type II<br/>Nitrites--metabolism<br/>Oligonucleotides--metabolism<br/>Precipitin Tests<br/>RNA, Messenger--biosynthesis<br/>Rats<br/>Rats, Sprague-Dawley<br/>Recombinant Proteins